IPO Plus

₹193.98

▲ +2.6 +1.36%

06 Aug 2026

NSE Listed · Pharmaceuticals

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-07-02
NSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-07-14

Kilitch Drugs (India) Ltd. (KILITCH)

Volume: 3,382Avg Vol 1W: 16,320Avg Vol 1M: 23,32252W Range:₹117.25₹227.23
NSE BSE www.kilitch.com AI Report
Key Ratios
Checked just now
Market Cap₹678 Cr
Current Price₹193.98
Previous Close₹191.38
High / Low (52w)₹227.23 / ₹117.25
Volume3,382
Avg Vol (1W)16,320
Avg Vol (1M)23,322
Stock P/E26.57
Book Value₹79.99
Dividend Yield0%
ROE10.79%
ROA6.44%
Revenue (TTM)—
Revenue Growth28.47%
Profit Margin12.81%
Total Debt₹28 Cr
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹7.3
P/B2.43
Debt / Equity0.32
50 DMA₹184.45
200 DMA₹170.55
Day change+1.36%
SurveillanceESM · ESM 1
Price Chart
₹193.98▼ 12.42% · 1Y
₹297₹12417.6L
2025-08-06
2026-08-06

20-day avg volume: 23K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 243% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹33 Cr₹47 Cr₹56 Cr₹61 Cr₹43 Cr₹49 Cr₹54 Cr₹90 Cr
EBITDA₹3 Cr₹11 Cr₹10 Cr₹15 Cr₹5 Cr₹11 Cr₹7 Cr₹22 Cr
Net Profit₹1 Cr₹9 Cr₹6 Cr₹10 Cr₹3 Cr₹8 Cr₹4 Cr₹15 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹47 Cr₹56 Cr₹209 Cr₹34 Cr₹38 Cr₹45 Cr₹247 Cr₹72 Cr
EBITDA₹10 Cr₹16 Cr₹40 Cr₹7 Cr₹11 Cr₹7 Cr₹44 Cr₹20 Cr
Net Profit₹7 Cr₹11 Cr₹27 Cr₹5 Cr₹9 Cr₹5 Cr₹30 Cr₹14 Cr
EPS——16.6———8.91—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹144 Cr₹143 Cr₹203 Cr₹210 Cr₹220 Cr₹240 Cr₹313 Cr₹458 Cr
Total Liabilities₹21 Cr₹22 Cr₹74 Cr₹70 Cr₹69 Cr₹64 Cr₹112 Cr₹181 Cr
Equity₹123 Cr₹120 Cr₹129 Cr₹140 Cr₹151 Cr₹176 Cr₹200 Cr₹277 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹4 Cr₹7 Cr₹47 Cr₹8 Cr₹7 Cr₹6 Cr₹26 Cr₹34 Cr
Investing₹-14 Cr₹-10 Cr₹-38 Cr₹-15 Cr₹8 Cr₹-8 Cr₹-40 Cr₹-100 Cr
Financing₹17 Cr₹1 Cr₹2 Cr₹7 Cr₹-1 Cr₹9 Cr₹13 Cr₹82 Cr
Free Cash Flow₹4 Cr₹7 Cr₹47 Cr₹8 Cr₹7 Cr₹6 Cr₹26 Cr₹35 Cr
Shareholding
Promoter 63.77% Institutions 0.12% Public 36.11%
Efficiency & Working Capital
ROCE12%
Interest Coverage7.1
Dividend Payout—
Debtor Days186 d
Inventory Days18 d
Payable Days123 d
Cash Conversion Cycle81 d
Working Capital Days204 d
Shareholding Details

As of 2026-06-30

Promoter63.8%
FII0.1%
DII0%
Institutions0.1%
Public36.1%
Promoter Pledge0%
No. of Shareholders12,627
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%63.8%63.8%63.8%63.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0.1%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%36.2%36.2%36.2%36.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders9,0029,0629,5259,6209,92010,1399,74910,37910,92912,04311,78512,627
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Kilitch Company (pharma) LimitedShareholding of Promoter and Promoter Group37.9%1.33 Cr
Bhavin Mukund MehtaShareholding of Promoter and Promoter Group14.4%50,46,276
Mukund MehtaShareholding of Promoter and Promoter Group6.6%23,09,294
Mira Bhavin MehtaShareholding of Promoter and Promoter Group4.8%16,82,092
Dipak Kanayalal ShahPublic Shareholding3.2%11,20,000
Mukul Mahavir AgrawalPublic Shareholding1.3%4,70,000
Premilaben Rameshchandra ShahPublic Shareholding1.1%4,00,000
Board of Directors
NameDesignationYear
Mukund P MehtaChairman & Managing Director2025
Bhavin M MehtaWTD & Executive Director2025
Mira MehtaManaging Director2025
VASUDEV KRISHNAMURTIIndependent Non Exe. Director2025
Venkita Subramanian RajanIndependent Non Exe. Director2025
DIPEN JAYANTILAL JAINIndependent Non Exe. Director2025
Pushpa NyoupaneCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
development and operations of Pharm₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10251616
Corporate Actions
TypeDateValueRemark
bonus2026-03-24Bonus issue 1:1—
bonus2026-03-241:11:1 Bonus Issue of Equity Shares
forthcoming—Book ClosureAGM
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20253002067
20253000063
2025000202
Insider / Designated-Person Trades

5 recent disclosure(s)

Mira Bhavin MehtaAcquisition · 8,41,046
Bhavin Mukund MehtaDisposal · 8,41,046
Bhavin Mukund MehtaAcquisition · 11,11,768
Mukund MehtaDisposal · 11,11,768
Mukund MehtaAcquisition · 11,11,768
Substantial Acquisitions (SAST)

4 disclosure(s)

-23/08/2024 · 8,41,046
Inter-se Transfer23/08/2024 · 8,41,046
Inter-se Transfer23/08/2024 · 8,41,046
NULL23/08/2024 · 8,41,046
Company Information
Incorporated1992
ChairmanMukund P Mehta
AuditorSuryaprakash Maurya & Co/C Sharat & Associates
Investor Email[email protected]
🌐 www.kilitch.com ↗

📍 C-301/2 MIDC TTC Indl Area, Pawane Village, Thane, Maharashtra, 400705

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Khadim India LimitedKhaitan Chemicals & Fertilizers Ltd.Khaitan (India)Ltd.Khandwala Securities Ltd.KHFM Hospitality & Facility Mgt. Services Ltd.Kalyani Investment Company Ltd.Krishna Institute of Medical Sciences Ltd.Kingfa Science & Technology (India) Ltd.KIOCL LimitedKiran Vyapar Ltd.Kiri Industries LimitedKirloskar Ferrous Industries Ltd.All “K” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App